205 related articles for article (PubMed ID: 29404807)
21. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Eisen A; Lubinski J; Gronwald J; Moller P; Lynch HT; Klijn J; Kim-Sing C; Neuhausen SL; Gilbert L; Ghadirian P; Manoukian S; Rennert G; Friedman E; Isaacs C; Rosen E; Rosen B; Daly M; Sun P; Narod SA;
J Natl Cancer Inst; 2008 Oct; 100(19):1361-7. PubMed ID: 18812548
[TBL] [Abstract][Full Text] [Related]
22. Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry.
Menes TS; Terry MB; Goldgar D; Andrulis IL; Knight JA; John EM; Liao Y; Southey M; Miron A; Chung W; Buys SS
Breast Cancer Res Treat; 2015 Jun; 151(3):653-60. PubMed ID: 25975955
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.
Vicus D; Finch A; Rosen B; Fan I; Bradley L; Cass I; Sun P; Karlan B; McLaughlin J; Narod SA;
Gynecol Oncol; 2010 Aug; 118(2):155-9. PubMed ID: 20452659
[TBL] [Abstract][Full Text] [Related]
24. Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.
Ginsburg O; Ghadirian P; Lubinski J; Cybulski C; Lynch H; Neuhausen S; Kim-Sing C; Robson M; Domchek S; Isaacs C; Klijn J; Armel S; Foulkes WD; Tung N; Moller P; Sun P; Narod SA;
Breast Cancer Res Treat; 2009 Mar; 114(1):127-35. PubMed ID: 18483851
[TBL] [Abstract][Full Text] [Related]
25. Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers.
Fakkert IE; Mourits MJ; Jansen L; van der Kolk DM; Meijer K; Oosterwijk JC; van der Vegt B; Greuter MJ; de Bock GH
Cancer Prev Res (Phila); 2012 Nov; 5(11):1291-7. PubMed ID: 23009828
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
Rennert G; Bisland-Naggan S; Barnett-Griness O; Bar-Joseph N; Zhang S; Rennert HS; Narod SA
N Engl J Med; 2007 Jul; 357(2):115-23. PubMed ID: 17625123
[TBL] [Abstract][Full Text] [Related]
27. The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy.
Pearson EJ; Nair A; Daoud Y; Blum JL
Breast Cancer Res Treat; 2017 Feb; 162(1):59-67. PubMed ID: 28066861
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.
Friedman E; Kotsopoulos J; Lubinski J; Lynch HT; Ghadirian P; Neuhausen SL; Isaacs C; Weber B; Foulkes WD; Moller P; Rosen B; Kim-Sing C; Gershoni-Baruch R; Ainsworth P; Daly M; Tung N; Eisen A; Olopade OI; Karlan B; Saal HM; Garber JE; Rennert G; Gilchrist D; Eng C; Offit K; Osborne M; Sun P; Narod SA;
Breast Cancer Res; 2006; 8(2):R15. PubMed ID: 16563180
[TBL] [Abstract][Full Text] [Related]
29. Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.
Nkondjock A; Robidoux A; Paredes Y; Narod SA; Ghadirian P
Breast Cancer Res Treat; 2006 Aug; 98(3):285-94. PubMed ID: 16541324
[TBL] [Abstract][Full Text] [Related]
30. Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age.
van Erkelens A; Derks L; Sie AS; Egbers L; Woldringh G; Prins JB; Manders P; Hoogerbrugge N
J Genet Couns; 2017 Aug; 26(4):785-791. PubMed ID: 27966054
[TBL] [Abstract][Full Text] [Related]
31. The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers.
Pettapiece-Phillips R; Narod SA; Kotsopoulos J
Cancer Causes Control; 2015 Mar; 26(3):333-44. PubMed ID: 25579073
[TBL] [Abstract][Full Text] [Related]
32. Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.
Chang-Claude J; Andrieu N; Rookus M; Brohet R; Antoniou AC; Peock S; Davidson R; Izatt L; Cole T; Noguès C; Luporsi E; Huiart L; Hoogerbrugge N; Van Leeuwen FE; Osorio A; Eyfjord J; Radice P; Goldgar DE; Easton DF; ; ; ;
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):740-6. PubMed ID: 17416765
[TBL] [Abstract][Full Text] [Related]
33. Physical Activity in Young BRCA Carriers and Reduced Risk of Breast Cancer.
Bucy AM; Valencia CI; Howe CL; Larkin TJ; Conard KD; Anderlik EW; Valdivi SI; Bea JW
Am J Prev Med; 2022 Nov; 63(5):837-845. PubMed ID: 35738959
[TBL] [Abstract][Full Text] [Related]
34. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
Gronwald J; Tung N; Foulkes WD; Offit K; Gershoni R; Daly M; Kim-Sing C; Olsson H; Ainsworth P; Eisen A; Saal H; Friedman E; Olopade O; Osborne M; Weitzel J; Lynch H; Ghadirian P; Lubinski J; Sun P; Narod SA;
Int J Cancer; 2006 May; 118(9):2281-4. PubMed ID: 16331614
[TBL] [Abstract][Full Text] [Related]
36. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.
Kiechle M; Engel C; Berling A; Hebestreit K; Bischoff SC; Dukatz R; Siniatchkin M; Pfeifer K; Grill S; Yahiaoui-Doktor M; Kirsch E; Niederberger U; Enders U; Löffler M; Meindl A; Rhiem K; Schmutzler R; Erickson N; Halle M
Trials; 2016 Jul; 17():368. PubMed ID: 27473440
[TBL] [Abstract][Full Text] [Related]
37. Lifetime physical activity and the risk of breast cancer: a case-control study.
Kruk J
Cancer Detect Prev; 2007; 31(1):18-28. PubMed ID: 17296272
[TBL] [Abstract][Full Text] [Related]
38. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
[TBL] [Abstract][Full Text] [Related]
39. The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.
Catucci I; Verderio P; Pizzamiglio S; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Ripamonti CB; Pasini B; Barile M; Viel A; Giannini G; Papi L; Varesco L; Martayan A; Riboni M; Volorio S; Radice P; Peterlongo P
Breast Cancer Res Treat; 2011 Feb; 125(3):855-60. PubMed ID: 20652397
[TBL] [Abstract][Full Text] [Related]
40. Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.
Kotsopoulos J; Lubinski J; Moller P; Lynch HT; Singer CF; Eng C; Neuhausen SL; Karlan B; Kim-Sing C; Huzarski T; Gronwald J; McCuaig J; Senter L; Tung N; Ghadirian P; Eisen A; Gilchrist D; Blum JL; Zakalik D; Pal T; Sun P; Narod SA;
Breast Cancer Res Treat; 2014 Feb; 143(3):579-86. PubMed ID: 24458845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
